|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0010055,
umls-concept:C0017887,
umls-concept:C0030705,
umls-concept:C0151744,
umls-concept:C0355642,
umls-concept:C0392756,
umls-concept:C0445202,
umls-concept:C0543467,
umls-concept:C0677582,
umls-concept:C1273870,
umls-concept:C2004454
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-2-7
|
|
pubmed:abstractText |
To evaluate the use of a high dose of nitroglycerin (NTG) for prophylaxis against myocardial ischemia and infarction in patients undergoing coronary artery bypass graft (CABG) surgery with accelerated recovery.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1053-0770
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
571-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11052441-Adult,
pubmed-meshheading:11052441-Coronary Artery Bypass,
pubmed-meshheading:11052441-Double-Blind Method,
pubmed-meshheading:11052441-Female,
pubmed-meshheading:11052441-Humans,
pubmed-meshheading:11052441-Male,
pubmed-meshheading:11052441-Middle Aged,
pubmed-meshheading:11052441-Myocardial Infarction,
pubmed-meshheading:11052441-Myocardial Ischemia,
pubmed-meshheading:11052441-Nitroglycerin,
pubmed-meshheading:11052441-Prospective Studies,
pubmed-meshheading:11052441-Vasodilator Agents
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Prophylactic nitroglycerin did not reduce myocardial ischemia during accelerated recovery management of coronary artery bypass graft surgery patients.
|
|
pubmed:affiliation |
Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1009, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
